ArticleCureus2025
Impact of Tuberculosis on People Living With HIV: A Deadly Enemy Revealed in a Cross-Sectional Study of the Colombian Caribbean.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe human immunodeficiency virus (HIV) destroys CD4 lymphocytes and weakens the immune system, exposing the body to opportunistic infections. People with impaired cellular immunity due to HIV are at greater risk of complications from tuberculosis (TB), which implies a poor health prognosis. When diagnostic and therapeutic interventions are not performed promptly, the outcome can be fatal.
objectiveThis study aimed to analyze the epidemiological behavior and factors associated with mortality in TB/HIV coinfection during the years 2015 to 2024 in the Department of Córdoba (Colombia). METHODOLOGY: A cross-sectional analytical study was conducted using retrospective data obtained from event 813 notification forms from the National Public Health Surveillance System (Sivigila). Clinical and sociodemographic data, as well as laboratory reports, were collected. The information is described using graphical methods and numerical indices (measures of central tendency and dispersion). Categorized qualitative and quantitative variables were analyzed using contingency tables, chi-square tests, and multiple logistic regression analysis.
resultsThe sociodemographic variables studied were not statistically significant. The variables "hospitalization," "type of case confirmation," and "smear microscopy result" were found to have a statistically significant association (p < 0.05) with the final event of interest (deceased or alive).
conclusionsAn explanatory statistical model for mortality in patients with HIV-TB coinfection was evaluated for the first time in the Department of Córdoba (Colombia). Hospitalization and clinical confirmation of the case are associated with a higher risk of mortality. Further research is needed, utilizing different design techniques and fewer limitations, to corroborate the proposed findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.